Gene · 9619
Papers3,998
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,998
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CircABCA1 promotes ccRCC by reprogramming cholesterol metabolism and facilitating M2 macrophage polarization through IGF2BP3-mediated stabilization of SCARB1 mRNA. | Mol Cancer | 2025 | 40684174 | PubTator, text mining | PubMed |
| DNA methylation levels are independently associated with prevalence of atherosclerotic cardiovascular disease in multifactorial chylomicronemia syndrome. | Clin Biochem | 2025 | 40664291 | PubTator, text mining | PubMed |
| Cyanidin-3-glucoside: targeting atherosclerosis through gut microbiota and anti-inflammation. | Front Nutr | 2025 | 40661680 | PubTator, text mining | PubMed |
| Association of ATP-binding cassette transporter genomic alterations and expressions with patient survival in breast and prostate cancer. | Physiol Rep | 2025 | 40641097 | PubTator, text mining | PubMed |
| Microenvironment responsive nanoplatform for targeted removal of cholesterol and reshaping inflammatory microenvironment in atherosclerotic plaques. | J Control Release | 2025 | 40628350 | PubTator, text mining | PubMed |
| Effectiveness, enjoyment, and meaningfulness of a virtual reality gait-based fall prevention exergame in community-dwelling healthy older adults: an interdisciplinary pilot study. | Front Psychol | 2025 | 40567879 | PubTator, text mining | PubMed |
| Differential Expression of Lipid Metabolism Genes, CROT and ABCG1, in Obese Patients with Comorbid Depressive Disorder and Risk of MASLD. | Metabolites | 2025 | 40559416 | PubTator, text mining | PubMed |
| Niclosamide Treatment Suppressed Metastatic, Apoptotic, and Proliferative Characteristics of MDA-MB-231 Cancer Stem Cells. | ACS Omega | 2025 | 40521512 | PubTator, text mining | PubMed |
| ABCG1 promotes the proliferation and migration of clear cell renal cell carcinoma and reduces its apoptosis. | Int J Med Sci | 2025 | 40520894 | PubTator, text mining | PubMed |
| Eicosapentaenoic acid inhibits cholesterol efflux pathways from cholesterol-loaded human THP-1 macrophages by reducing the hydrolysis of cholesteryl esters mediated by carboxylesterase 1. | Biochim Biophys Acta Mol Cell Biol Lipids | 2025 | 40517886 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction fuels drug resistance in adult T-cell acute lymphoblastic leukemia. | J Transl Med | 2025 | 40369632 | PubTator, text mining | PubMed |
| Mediterranean Diet Modulates Gene Expression of Cholesterol Efflux Receptors in High-Risk Cardiovascular Patients. | Mol Nutr Food Res | 2025 | 40344371 | PubTator, text mining | PubMed |
| [Retracted] ABCG1 as a potential oncogene in lung cancer. | Exp Ther Med | 2025 | 40236983 | PubTator, text mining | PubMed |
| Association Between ABCG1/TCF7L2 and Type 2 Diabetes Mellitus: An Intervention Trial Based on a Case-Control Study. | J Diabetes Res | 2025 | 40225014 | PubTator, text mining | PubMed |
| Message hidden in α-helices-toward a better understanding of plant ABCG transporters' multispecificity. | Plant Physiol | 2025 | 40220341 | PubTator, text mining | PubMed |
| Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia. | Eur J Med Res | 2025 | 40211340 | PubTator, text mining | PubMed |
| A computationally efficient approach to false discovery rate control and power maximisation via randomisation and mirror statistic. | Stat Methods Med Res | 2025 | 40165448 | PubTator, text mining | PubMed |
| Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients. | Biomedicines | 2025 | 40149530 | PubTator, text mining | PubMed |
| Ark Shell-Derived Peptides AWLNH (P3) and PHDL (P4) Mitigate Foam Cell Formation by Modulating Cholesterol Metabolism and HO-1/Nrf2-Mediated Oxidative Stress in Atherosclerosis. | Mar Drugs | 2025 | 40137297 | PubTator, text mining | PubMed |
| Deciphering the effective components of a TCM formula for atherosclerosis by three-dimensional pattern recognition of exogenous components correlated with endogenous metabolites. | J Ethnopharmacol | 2025 | 40120703 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9619/papers?page=7